Alicorn Pharmaceutical Co., Ltd Company Profile,Alicorn Pharmaceutical Co., Ltd Essential Information

Company Profile

Our Company Our Business

Year Established : 2021

Total Assets(USD) : 500,000 to 99,999,999

Total Number of Staff : 100-500

Main Competitive Advantages : International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing (CRO,CMO),Reputation,Quality Service

Other Competitive Advantages : Three R&D centers and one manufacturing base. Nanjing R&D center It covers an area of 1800 square meters,mainly dedicated in the process research and optimization of APIs 、pharmaceutical intermediates、solid & liquid drugs and quality & stability research. Jiaxing R&D center It covers an area of over 3500 square meters,mainly participated in the customization and synthesis of new molecular compound. Anqing Technical center ( under construction) The lab has an area of 1200 square meters,mainly used for the process optimization、finalize、scale-up and costing control of APIs and pharmaceutical intermediates. Anqing manufacturing site. The APIs & intermediates manufacturing site covers an area of 15000 square meters, the 500-5000L reactors can be available for specific reactions including high temperature、high pressure、cryogenic and hydrogenation reactions The final drugs manufacturing site has an area of 11000 square meters for the production of oral solid drugs and external drugs.

Patents and Copyrights : We have applied several patents for the R&D of APIs and drugs

Send Inquiry

Alicorn Pharmaceutical Co., Ltd
Contact Person : Wang Zhenjie
Tel: Click to View
Fax: --

Alicorn pharmaceutical Co.,Ltd is a national high-tech enterprise engaged in the R&D and manufacturing of innovative drugs、modified new drugs、generic drugs and pharmaceutical intermediates.It has been been equipped with two R&D centers respectively in Nanjing Jiangsu province and Jiaxing Zhejiang province of China.Our own wholly owned manufacturing site is located in Anqing high-tech industry zone of Anhui province,the manufacturing site is used to produce the APIs and final drugs covering an area of 72mu.

Certificates/Standards

Jiangsu private science & Technology company

Jiangsu science & Technology company

National high-tech enterprises

Company Profile of Alicorn Pharmaceutical Co., Ltd

Company Profile